Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Exercising women with irregular periods have lower thyroid hormone levels and less body fat.

Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men with AGA.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

Androgenetic alopecia causes hair loss, and early, ongoing treatment is key for best results.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Young men with early baldness may have lower Luteinizing Hormone levels due to higher dihydrotestosterone, possibly linked to certain drugs or gland disorders.

Antiandrogen treatment helps reduce hair follicles and sebaceous glands in hirsute women.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Neurosteroid withdrawal increases α4 subunit expression in the hippocampus, which may relate to catamenial epilepsy in women.

Apoptosis contributes to hair loss in androgenetic alopecia.

Hair loss increases with age and is triggered by hormones like androgens.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

The document says that Androgenetic alopecia, a common hair loss condition, affects women less often and usually less severely, but early diagnosis and treatment are important.

Spironolactone is generally safe and effective for treating hair loss in women, but may be less effective in severe cases.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

ACOD1 deficiency worsens hair loss by causing cell aging and mitochondrial problems, but 4-OI may help.

The patient was diagnosed with anorexia nervosa and severe malnutrition, requiring urgent refeeding and monitoring.